Clinical Trial Update: Randomized, Placebo-controlled Trial of Ferric Carboxymaltose in RLS Patients With Iron-deficiency Anemia [Phase 2]

View source ↗

Summary

Phase 2 randomized, placebo-controlled trial of ferric carboxymaltose in restless legs syndrome with iron-deficiency anemia was terminated. Results have been po…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Restless Legs Syndrome

Drugs mentioned

• Ferric carboxymaltose (ferric carboxymaltose)

Snippet

Sponsor: American Regent, Inc. | Conditions: Restless Legs Syndrome (RLS) | Phase 2 | Status: TERMINATED | Results posted: 2022-09-14